|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 883.75 INR | -1.88% |
|
-4.72% | -3.35% |
| Jan. 13 | US FDA approves Fortress Bio and Zydus' treatment for a rare pediatric disease | RE |
| Jan. 13 | Zydus Lifesciences Receives US FDA Nod for Rare Pediatric Disease Drug | MT |
2785ebd2f3.iTxXimJTVXcGM0N4tNCPX4XLWuLIYjhLDQvKpIyWKW8.2UQ43TUwIkdjCyBA0pm4CvepPJWvJUsOQkj-k_XXfjrlS2P7VD4UREVxcw~bbc293bb05d91cb5414080df4f7fb56c
Select your edition
All financial news and data tailored to specific country editions
